ABUS

#2156
Arbutus Biopharma Corporation Common Stock
4.66
-0.64%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
4.66
4.66
Годовой диапазон
2.71
5.10
Дневное изменение
-0.64%
Месячное изменение
+11.75%
6-месячное изменение
+27.32%
Годовое изменение
+38.69%
Предыдущее закрытие
4.69
Open
4.66
Bid
Ask
Low
4.66
High
4.66
Объем
230
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Новости